CN
Search Within
200-353-2
Applied Filters:
Keyword:'200-353-2'
Showing 1-4 of 4 results for "200-353-2" within Papers
Yamin Liu et al.
Environmental science & technology, 45(13), 5710-5716 (2011-06-16)
A novel solid amine sorbent was prepared using KIT-6-type mesoporous silica modified with tetraethylenepentamine (TEPA). Its adsorption behavior toward CO(2) from simulated flue gases is investigated using an adsorption column. The adsorption capacities at temperatures of 303, 313, 333, 343
I J Chopra et al.
Thyroid : official journal of the American Thyroid Association, 6(4), 255-259 (1996-08-01)
We have devised a practical, sensitive, and reliable assay for measurement of free T3 concentration in serum. The assay employs a convenient and disposable plastic equilibrium dialysis cell and a buffer that resembles the in vivo biochemical environment (Nelson JC
Loreto Martorell et al.
Clinical rheumatology, 31(11), 1611-1615 (2012-08-21)
Fragile X mental retardation 1 (FMR1) premutation carriers, who are at risk of having children with fragile X Syndrome, were initially considered as clinically unaffected. However, recent clinical and molecular studies have shifted this point of view. The incidence of
Maheshi N Ramasamy et al.
Lancet (London, England), 396(10267), 1979-1993 (2020-11-23)
Older adults (aged ≥70 years) are at increased risk of severe disease and death if they develop COVID-19 and are therefore a priority for immunisation should an efficacious vaccine be developed. Immunogenicity of vaccines is often worse in older adults
Page 1 of 1